Company Description

Exvade is a biotech company pioneering a novel approach to treating malignant brain tumors. Using bio-inspired cues, their technology guides invasive intracortical tumor cells along a “monorail” to an extracortical reservoir—creating a safe and accessible zone for removal and analysis.